Earth Science Tech (ETST) Non Operating Income (2018 - 2024)
Earth Science Tech's (ETST) quarterly Non Operating Income came in at -$13658.0 in Q1 2024, up 88.24% on a YoY basis from -$7255.4 in Q2 2023, and down 144.42% quarter-over-quarter from -$5588.0 in Q4 2023.
Powered by 
Analysis
Earth Science Tech (ETST) Non Operating Income (2018 - 2024) Analysis & Trends
Earth Science Tech (ETST) has reported Non Operating Income for 7 consecutive years, with -$13658.0 the latest figure, recorded in Q1 2024.
- For the quarter ending Q1 2024, Non Operating Income rose 88.24% year-over-year to -$13658.0; the trailing twelve-month figure through Mar 2024 stood at -$67227.0 (down 384.02% YoY), and the FY2024 full-year result was -$67207.0, down 111.76% from the prior year.
- Non Operating Income retreated to -$13658.0 in Q1 2024 per ETST's latest filing, from -$5588.0 in the prior quarter.
- Across five years, Non Operating Income topped out at $3.4 million in Q3 2021 and bottomed at -$130379.0 in Q1 2020.
- Historically, Non Operating Income has averaged $184971.8 across 5 years, with a median of -$12604.0 in 2020.
- The sharpest annual moves came in 2021 and 2023: Non Operating Income soared 27211.56% in 2021, then tumbled 1193.14% in 2023.
- Over 5 years, Non Operating Income stood at -$29793.0 in 2020, then jumped by 52.68% to -$14097.0 in 2021, then surged by 1140.92% to $146739.0 in 2022, then plunged by 103.81% to -$5588.0 in 2023, then tumbled by 144.42% to -$13658.0 in 2024.
- According to Business Quant data, Non Operating Income over the past three periods registered -$13658.0, -$5588.0, and -$35363.0 for Q1 2024, Q4 2023, and Q3 2023 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.61 Bn | 38.95 Bn | 2.15 Bn | -224.00 Mn |
| 2 | Viatris | 19.18 Bn | 18.30 Bn | 1.46 Bn | - |
| 3 | Dr Reddys Laboratories | 9.85 Bn | 9.68 Bn | 396.53 Mn | - |
| 4 | Amneal Pharmaceuticals | 5.48 Bn | 5.35 Bn | 334.51 Mn | -58.78 Mn |
| 5 | Bausch Health Companies | 2.36 Bn | 518.87 Mn | 2.10 Bn | - |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | - |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | - |
| 8 | Amphastar Pharmaceuticals | 994.21 Mn | 704.09 Mn | 93.47 Mn | -1.19 Mn |
| 9 | Fennec Pharmaceuticals | 405.56 Mn | 364.31 Mn | 17.15 Mn | 278,000.00 |
| 10 | Earth Science Tech | 25.88 Mn | 23.09 Mn | 6.28 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2024 | -13,658.00 |
| Dec 31, 2023 | -5,588.00 |
| Sep 30, 2023 | -35,363.00 |
| Jun 30, 2023 | -12,618.00 |
| Mar 31, 2023 | -116,186.00 |
| Dec 31, 2022 | 146,739.00 |
| Sep 30, 2022 | 3,235.00 |
| Jun 30, 2022 | -10,118.00 |
| Mar 31, 2022 | 37,342.00 |
| Dec 31, 2021 | -14,097.00 |
| Sep 30, 2021 | 3.39 Mn |
| Jun 30, 2021 | -10,868.00 |
| Mar 31, 2021 | -26,617.00 |
| Dec 31, 2020 | -29,793.00 |
| Sep 30, 2020 | -12,495.00 |
| Jun 30, 2020 | -12,604.00 |
| Mar 31, 2020 | -130,379.00 |
| Dec 31, 2019 | 15,987.00 |
| Sep 30, 2019 | -12,720.00 |
| Jun 30, 2019 | -164,574.00 |